Beam Therapeutics Inc.
MX ˙ BMV ˙ US07373V1052
SecurityMX:BEAM / Beam Therapeutics Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership528,970 shares
Latest Disclosed Value $ 12,605,355
Citadel Advisors Llc ownership in BEAM / Beam Therapeutics Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 528,970 shares of Beam Therapeutics Inc. (MX:BEAM) valued at $12,605,355 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 255,710 shares of Beam Therapeutics Inc.. This represents a change in shares of 106.86% during the quarter.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (BEAM) in the form of stock options. The firm currently holds call options representing 232,400 of underlying shares valued at $5,538,092 USD and put options representing 44,700 of underlying shares valued at $1,065,201 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BEAM / Beam Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BEAM THERAPEUTICS COM 07373V105 528,970 273,260 106.86 12,605 77.84 0.0018
2026-02-17 2025-12-31 13F BEAM THERAPEUTICS COM 07373V105 255,710 255,710 7,088 0.0011
2025-11-14 2025-09-30 13F BEAM THERAPEUTICS COM 07373V105 0 -2,337,517 -100.00 0 -100.00
2025-08-14 2025-06-30 13F BEAM THERAPEUTICS COM 07373V105 2,337,517 -162,830 -6.51 39,761 -18.57 0.0069
2025-05-15 2025-03-31 13F BEAM THERAPEUTICS COM 07373V105 2,500,347 438,101 21.24 48,832 -4.52 0.0093
2025-02-14 2024-12-31 13F BEAM THERAPEUTICS COM 07373V105 2,062,246 566,051 37.83 51,144 39.52 0.0089
2024-11-14 2024-09-30 13F BEAM THERAPEUTICS COM 07373V105 1,496,195 727,041 94.52 36,657 103.41 0.0071
2024-08-14 2024-06-30 13F BEAM THERAPEUTICS COM 07373V105 769,154 729,641 1,846.58 18,021 1,280.92 0.0036
2024-05-15 2024-03-31 13F BEAM THERAPEUTICS COM 07373V105 39,513 28,068 245.24 1,306 319.61 0.0003
2024-02-14 2023-12-31 13F BEAM THERAPEUTICS COM 07373V105 11,445 -1,165,470 -99.03 312 -98.90 0.0001
2023-11-14 2023-09-30 13F BEAM THERAPEUTICS COM 07373V105 1,176,915 857,371 268.31 28,305 177.41 0.0061
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM 07373V105 319,544 138,344 76.35 10,203 83.90 0.0021
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM 07373V105 181,200 51,938 40.18 5,548 9.75 0.0012
2023-02-14 2022-12-31 13F BEAM THERAPEUTICS COM 07373V105 129,262 34,930 37.03 5,055 12.48 0.0012
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM 07373V105 94,332 41,000 76.88 4,494 117.73 0.0010
2022-08-15 2022-06-30 13F BEAM THERAPEUTICS COM 07373V105 53,332 -111,186 -67.58 2,064 -78.11 0.0005
2022-05-16 2022-03-31 13F BEAM THERAPEUTICS COM 07373V105 164,518 83,789 103.79 9,427 46.54 0.0019
2022-02-14 2021-12-31 13F BEAM THERAPEUTICS COM 07373V105 80,729 -135,463 -62.66 6,433 -65.80 0.0013
2021-11-15 2021-09-30 13F BEAM THERAPEUTICS Cmn 07373V105 216,192 194,580 900.33 18,811 576.17 0.0039
2021-08-16 2021-06-30 13F BEAM THERAPEUTICS COM 07373V105 21,612 -135,705 -86.26 2,782 -77.91 0.0006
2021-05-21 2021-03-31 13F/A-1 BEAM THERAPEUTICS COM 07373V105 157,317 147,684 1,533.10 12,592 1,502.04 0.0031
2021-05-17 2021-03-31 13F BEAM THERAPEUTICS COM 07373V105 157,317 147,684 12,592 0.0031
2021-02-16 2020-12-31 13F BEAM THERAPEUTICS COM 07373V105 9,633 9,633 786 0.0002
2020-11-16 2020-09-30 13F BEAM THERAPEUTICS Cmn 07373V105 0 -27,126 -100.00 0 -100.00
2020-08-14 2020-06-30 13F BEAM THERAPEUTICS Cmn 07373V105 27,126 -59,173 -68.57 759 -51.13 0.0003
2020-05-15 2020-03-31 13F BEAM THERAPEUTICS Cmn 07373V105 86,299 86,299 1,553 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BEAM THERAPEUTICS COM Call 232,400 6.17 5,538 -8.72 n/a n/a n/a
2026-02-17 2025-12-31 13F BEAM THERAPEUTICS COM Call 218,900 -16.42 6,068 -4.55 n/a n/a n/a
2025-11-14 2025-09-30 13F BEAM THERAPEUTICS COM Call 261,900 33.62 6,356 90.70 n/a n/a n/a
2025-08-14 2025-06-30 13F BEAM THERAPEUTICS COM Call 196,000 270.51 3,334 222.65 n/a n/a n/a
2025-05-15 2025-03-31 13F BEAM THERAPEUTICS COM Call 52,900 3.12 1,033 -18.79 n/a n/a n/a
2025-02-14 2024-12-31 13F BEAM THERAPEUTICS COM Call 51,300 -44.78 1,272 -44.11 n/a n/a n/a
2024-11-14 2024-09-30 13F BEAM THERAPEUTICS COM Call 92,900 13.43 2,276 18.67 n/a n/a n/a
2024-08-14 2024-06-30 13F BEAM THERAPEUTICS COM Call 81,900 67.48 1,919 18.76 n/a n/a n/a
2024-05-15 2024-03-31 13F BEAM THERAPEUTICS COM Call 48,900 -18.50 1,616 -1.10 n/a n/a n/a
2024-02-14 2023-12-31 13F BEAM THERAPEUTICS COM Call 60,000 -56.40 1,633 -50.65 n/a n/a n/a
2023-11-14 2023-09-30 13F BEAM THERAPEUTICS COM Call 137,600 402.19 3,309 278.60 n/a n/a n/a
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM Call 27,400 -58.98 875 -57.26 n/a n/a n/a
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM Call 66,800 10.96 2,045 -13.13 n/a n/a n/a
2023-02-14 2022-12-31 13F BEAM THERAPEUTICS COM Call 60,200 -71.00 2,354 -76.20 n/a n/a n/a
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM Call 207,600 177.54 9,890 241.51 n/a n/a n/a
2022-08-15 2022-06-30 13F BEAM THERAPEUTICS COM Call 74,800 -37.14 2,896 -57.53 n/a n/a n/a
2022-05-16 2022-03-31 13F BEAM THERAPEUTICS COM Call 119,000 34.46 6,819 -3.32 n/a n/a n/a
2022-02-14 2021-12-31 13F BEAM THERAPEUTICS COM Call 88,500 12.74 7,053 3.27 n/a n/a n/a
2021-11-15 2021-09-30 13F BEAM THERAPEUTICS Cmn Call 78,500 1.42 6,830 -31.44 n/a n/a n/a
2021-08-16 2021-06-30 13F BEAM THERAPEUTICS COM Call 77,400 39.96 9,962 125.08 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BEAM THERAPEUTICS COM Call 55,300 5.53 4,426 3.46 n/a n/a n/a
2021-05-17 2021-03-31 13F BEAM THERAPEUTICS COM Call 55,300 4,426 n/a n/a n/a
2021-02-16 2020-12-31 13F BEAM THERAPEUTICS COM Call 52,400 4,278 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BEAM THERAPEUTICS COM Put 44,700 30.70 1,065 12.34 n/a n/a n/a
2026-02-17 2025-12-31 13F BEAM THERAPEUTICS COM Put 34,200 -74.31 948 -70.65 n/a n/a n/a
2025-11-14 2025-09-30 13F BEAM THERAPEUTICS COM Put 133,100 -45.92 3,230 -22.84 n/a n/a n/a
2025-08-14 2025-06-30 13F BEAM THERAPEUTICS COM Put 246,100 65.72 4,186 44.34 n/a n/a n/a
2025-05-15 2025-03-31 13F BEAM THERAPEUTICS COM Put 148,500 113.06 2,900 67.82 n/a n/a n/a
2025-02-14 2024-12-31 13F BEAM THERAPEUTICS COM Put 69,700 17.94 1,729 19.42 n/a n/a n/a
2024-11-14 2024-09-30 13F BEAM THERAPEUTICS COM Put 59,100 -31.60 1,448 -28.51 n/a n/a n/a
2024-08-14 2024-06-30 13F BEAM THERAPEUTICS COM Put 86,400 -19.85 2,024 -43.16 n/a n/a n/a
2024-05-15 2024-03-31 13F BEAM THERAPEUTICS COM Put 107,800 122.27 3,562 169.77 n/a n/a n/a
2024-02-14 2023-12-31 13F BEAM THERAPEUTICS COM Put 48,500 -51.35 1,320 -44.93 n/a n/a n/a
2023-11-14 2023-09-30 13F BEAM THERAPEUTICS COM Put 99,700 67.56 2,398 26.22 n/a n/a n/a
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM Put 59,500 -56.66 1,900 -54.83 n/a n/a n/a
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM Put 137,300 -22.21 4,204 -39.09 n/a n/a n/a
2023-02-14 2022-12-31 13F BEAM THERAPEUTICS COM Put 176,500 65.57 6,903 35.92 n/a n/a n/a
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM Put 106,600 9.67 5,078 34.95 n/a n/a n/a
2022-08-15 2022-06-30 13F BEAM THERAPEUTICS COM Put 97,200 30.65 3,763 -11.73 n/a n/a n/a
2022-05-16 2022-03-31 13F BEAM THERAPEUTICS COM Put 74,400 47.91 4,263 6.36 n/a n/a n/a
2022-02-14 2021-12-31 13F BEAM THERAPEUTICS COM Put 50,300 -26.68 4,008 -32.85 n/a n/a n/a
2021-11-15 2021-09-30 13F BEAM THERAPEUTICS Cmn Put 68,600 62.56 5,969 9.89 n/a n/a n/a
2021-08-16 2021-06-30 13F BEAM THERAPEUTICS COM Put 42,200 -42.19 5,432 -7.03 n/a n/a n/a
2021-05-21 2021-03-31 13F/A BEAM THERAPEUTICS COM Put 73,000 71.36 5,843 68.00 n/a n/a n/a
2021-05-17 2021-03-31 13F BEAM THERAPEUTICS COM Put 73,000 5,843 n/a n/a n/a
2021-02-16 2020-12-31 13F BEAM THERAPEUTICS COM Put 42,600 3,478 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.